BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27588395)

  • 1. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells.
    Barbutti I; Xavier-Ferrucio JM; Machado-Neto JA; Ricon L; Traina F; Bohlander SK; Saad ST; Archangelo LF
    Oncotarget; 2016 Oct; 7(42):68385-68396. PubMed ID: 27588395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation.
    Barbutti I; Machado-Neto JA; Arfelli VC; de Melo Campos P; Traina F; Saad STO; Archangelo LF
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):959-966. PubMed ID: 29307747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CALM and CALM/AF10 interactor CATS is a marker for proliferation.
    Archangelo LF; Greif PA; Hölzel M; Harasim T; Kremmer E; Przemeck GK; Eick D; Deshpande AJ; Buske C; de Angelis MH; Saad ST; Bohlander SK
    Mol Oncol; 2008 Dec; 2(4):356-67. PubMed ID: 19383357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
    Archangelo LF; Gläsner J; Krause A; Bohlander SK
    Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
    BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.
    Machado-Neto JA; Lazarini M; Favaro P; de Melo Campos P; Scopim-Ribeiro R; Franchi Junior GC; Nowill AE; Lima PR; Costa FF; Benichou S; Olalla Saad ST; Traina F
    Biochim Biophys Acta; 2015 Mar; 1853(3):583-93. PubMed ID: 25523139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS).
    Archangelo LF; Greif PA; Maucuer A; Manceau V; Koneru N; Bigarella CL; Niemann F; dos Santos MT; Kobarg J; Bohlander SK; Saad ST
    Biochim Biophys Acta; 2013 May; 1833(5):1269-79. PubMed ID: 23419774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes.
    Nakamaki T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Hino Ki; Tomoyasu S; Honma Y; Kasukabe T
    Exp Hematol; 2002 May; 30(5):421-9. PubMed ID: 12031648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic inhibition of vascular endothelial growth factor receptor-1 significantly inhibits the migration and proliferation of leukemia cells and increases their sensitivity to chemotherapy.
    Xiu B; Zhang W; Huang B; Chen J; Lu H; Fu J; Xiong H; Liang A
    Oncol Rep; 2013 May; 29(5):2030-8. PubMed ID: 23503608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Cycle-Related FAM64A Could be Activated by TGF-β Signaling to Promote Glioma Progression.
    Fu M; Zhang J; Zhang L; Feng Y; Fang X; Zhang J; Wen W; Hua W; Mao Y
    Cell Mol Neurobiol; 2023 Aug; 43(6):2975-2987. PubMed ID: 37081231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.
    Dhyani A; Machado-Neto JA; Favaro P; Saad ST
    Eur J Cancer; 2015 Jan; 51(2):252-9. PubMed ID: 25483783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
    Wang J; Yao Y; Ming Y; Shen S; Wu N; Liu J; Liu H; Suo T; Pan H; Zhang D; Ding K; Liu H
    Sci Rep; 2016 Jun; 6():28833. PubMed ID: 27349455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.
    Caudell D; Zhang Z; Chung YJ; Aplan PD
    Cancer Res; 2007 Sep; 67(17):8022-31. PubMed ID: 17804713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
    Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
    Pichiorri F; Trapasso F; Palumbo T; Aqeilan RI; Drusco A; Blaser BW; Iliopoulos D; Caligiuri MA; Huebner K; Croce CM
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3494-501. PubMed ID: 16740775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
    Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
    Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.